228 related articles for article (PubMed ID: 12596356)
1. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
2. Commentary: where and how could biomarkers be used in 2016?
Finley Austin MJ; Babiss L
AAPS J; 2006; 8(1):E185-9. PubMed ID: 16596744
[TBL] [Abstract][Full Text] [Related]
3. Shifting emphasis from pharmacogenomics to theragnostics.
Ozdemir V; Williams-Jones B; Glatt SJ; Tsuang MT; Lohr JB; Reist C
Nat Biotechnol; 2006 Aug; 24(8):942-6. PubMed ID: 16900136
[TBL] [Abstract][Full Text] [Related]
4. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.
Hasanzadeh A; Ebadati A; Dastanpour L; Aref AR; Sahandi Zangabad P; Kalbasi A; Dai X; Mehta G; Ghasemi A; Fatahi Y; Joshi S; Hamblin MR; Karimi M
ACS Pharmacol Transl Sci; 2023 Dec; 6(12):1758-1779. PubMed ID: 38093832
[TBL] [Abstract][Full Text] [Related]
5. Role and implications of nanodiagnostics in the changing trends of clinical diagnosis.
Alharbi KK; Al-Sheikh YA
Saudi J Biol Sci; 2014 Apr; 21(2):109-17. PubMed ID: 24600302
[TBL] [Abstract][Full Text] [Related]
6. Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.
Li A; Meyre D
Curr Psychiatry Rev; 2014 May; 10(2):118-132. PubMed ID: 25598768
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus therapeutics and pharmacogenomics.
Shankarkumar U; Shankarkumar A; Ghosh K
Indian J Hum Genet; 2011 May; 17 Suppl 1(Suppl 1):S22-6. PubMed ID: 21747583
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: the MedeA initiative.
LLerena A; Peñas-LLedó E; de Andrés F; Mata-Martín C; Sánchez CL; Pijierro A; Cobaleda J
Drug Metab Pers Ther; 2020 Sep; ():. PubMed ID: 32877361
[No Abstract] [Full Text] [Related]
9. A safer way to share health data.
O'Leary K
Nat Med; 2021 Jun; ():. PubMed ID: 34113013
[No Abstract] [Full Text] [Related]
10. PERSONALIZED MEDICINE: FROM GENOTYPES AND MOLECULAR PHENOTYPES TOWARDS COMPUTED THERAPY.
Stegle O; Brenner SE; Morris Q; Listgarten J
Pac Symp Biocomput; 2013; 18():171-174. PubMed ID: 23424122
[No Abstract] [Full Text] [Related]
11. Evolving diagnostic imaging education: Aligning with personalized medicine.
Kalchev E
J Med Imaging Radiat Sci; 2024 Feb; 55(4):101386. PubMed ID: 38403522
[No Abstract] [Full Text] [Related]
12. Genotype-informed treatment for stroke.
O'Leary K
Nat Med; 2022 Feb; ():. PubMed ID: 35136232
[No Abstract] [Full Text] [Related]
13. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
14. Personalised medicine for cancer: from drug development into clinical practice.
Jain KK
Expert Opin Pharmacother; 2005 Aug; 6(9):1463-76. PubMed ID: 16086635
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine: progress and promise.
Chan IS; Ginsburg GS
Annu Rev Genomics Hum Genet; 2011; 12():217-44. PubMed ID: 21721939
[TBL] [Abstract][Full Text] [Related]
16. Personalized medicine: motivation, challenges, and progress.
Goetz LH; Schork NJ
Fertil Steril; 2018 Jun; 109(6):952-963. PubMed ID: 29935653
[TBL] [Abstract][Full Text] [Related]
17. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
18. Investigation toward the economic feasibility of personalized medicine for healthcare service providers: the case of bladder cancer.
Savchenko E; Bunimovich-Mendrazitsky S
Front Med (Lausanne); 2024; 11():1388685. PubMed ID: 38808135
[TBL] [Abstract][Full Text] [Related]
19. Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products.
Zhou Y; Peng S; Wang H; Cai X; Wang Q
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674402
[TBL] [Abstract][Full Text] [Related]
20. Enhancing antioxidant delivery through 3D printing: a pathway to advanced therapeutic strategies.
Alogla A
Front Bioeng Biotechnol; 2023; 11():1256361. PubMed ID: 37860625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
